Versed (Midazolam)

Midazolam is a medicine used to help people relax and feel sleepy. It's often used before procedures like dental work or surgery. It helps calm people down and makes them less anxious. It's also used to help with breathing during surgery.

Brand names:Versed
Medication

What people taking Versed (Midazolam) report

Every report comes from a Lived member, sent anonymously.

NameHow it went

No reports yet

Add what worked for you with the search bar below

About Versed (Midazolam)

What It's For

Midazolam is a fast-acting sedative in the benzodiazepine family, the same drug group as diazepam (Valium) and lorazepam (Ativan). Most people meet it in a hospital, surgery center or dental office, where it is given before or during a procedure to ease anxiety, cause drowsiness and blur memory of the experience. It is widely used for endoscopies such as colonoscopy, heart catheterization, imaging tests, minor surgery and before general anesthesia. In intensive care, a continuous drip keeps people calm while a breathing machine supports them. Children may receive a liquid dose by mouth before a procedure. Midazolam also stops seizures. Nayzilam, a nasal spray, is prescribed for people with epilepsy aged 12 and older whose seizures sometimes come in clusters, a burst of repeated seizures that differs from their usual pattern. It lets a trained family member or caregiver treat the cluster at home. Emergency teams also use injected midazolam for a seizure that will not stop. Versed was the original brand name. It has been discontinued in the US, but generic midazolam injection and syrup are widely used, and many clinicians still call it Versed.

How It Works

GABA (gamma-aminobutyric acid) is the brain's main calming chemical messenger: it makes nerve cells less likely to fire. Midazolam attaches to the GABA receptor and strengthens that signal, which slows brain activity. At low doses this relieves anxiety and causes drowsiness. At higher doses it deepens sedation and, given into a vein, can induce anesthesia. The same calming effect is what interrupts the runaway electrical activity of a seizure. Midazolam acts quickly and, compared with older benzodiazepines, wears off fairly fast. Through a vein, sedation begins within 3 to 5 minutes; a muscle injection takes about 15 minutes. A hallmark effect is amnesia: many people remember little or nothing of the procedure, even if they were awake enough to follow instructions.

Dosage & Administration

In medical settings, midazolam is given as an injection into a vein (IV) or muscle, or as a liquid for children to drink. There is no standard dose. The clinician gives a small amount, waits a few minutes to see the effect and adds more only if needed, using lower doses for older adults, people with lung or heart disease and anyone also receiving opioid pain medicine. Because midazolam can slow or stop breathing, it is given only where staff continuously monitor breathing, oxygen levels and heart rhythm and have oxygen, breathing equipment and a reversal medicine, flumazenil, at hand. The liquid is not for home use. Follow the facility's instructions about not eating or drinking beforehand. Nayzilam is a single-use nasal spray containing 5 mg. A caregiver gives one spray into one nostril when a seizure cluster starts. If the seizures have not stopped after 10 minutes, a second spray may be given in the other nostril, but only if the prescriber has said to. Do not give a second dose if the person is having trouble breathing or is much sleepier than usual after a seizure. Use no more than two doses for one cluster, treat no more than one cluster every three days and no more than five a month. Do not prime or test the device, since each unit sprays only once.

Side Effects

Drowsiness and patchy memory for several hours are expected rather than side effects in the usual sense. After an injection, some people notice hiccups, nausea or vomiting, headache, or pain and tenderness where the needle went in. Nayzilam commonly causes sleepiness, headache, a runny nose, nasal discomfort and throat irritation. Occasionally midazolam has the opposite of its intended effect, causing agitation, restlessness or combativeness, which is more common in children and older adults; the care team manages this if it happens. The most serious risk is slowed or shallow breathing, which can progress to stopped breathing. In a monitored setting, staff watch for this and can treat it immediately. At home after Nayzilam, get emergency help right away (call 911) if the person's breathing is slow or shallow, they are extremely sleepy or hard to wake, or the seizures do not stop after the spray.

Interactions & Warnings

Combining midazolam with opioids, such as oxycodone, hydrocodone, morphine or fentanyl, can cause deep sedation, dangerously slowed breathing, coma and death. Alcohol, sleep medicines, other benzodiazepines, muscle relaxants and some antipsychotics add to the same effect. Clinicians often combine midazolam with an opioid during procedures, which is one reason close monitoring is required. At home, avoid alcohol and other sedating drugs around Nayzilam use unless the prescriber has approved them. Some medicines slow the liver's breakdown of midazolam and can make sedation last much longer. These include the antibiotics erythromycin and clarithromycin, the antifungals ketoconazole and itraconazole, and the heart and blood pressure medicines diltiazem and verapamil. Before a procedure, give the team a full list of prescriptions, supplements and recent alcohol use. Midazolam should not be used by people with acute narrow-angle glaucoma, an eye condition in which pressure inside the eye rises suddenly. People with treated open-angle glaucoma can usually receive it. Used late in pregnancy, it can leave a newborn sleepy, floppy or with withdrawal symptoms, so the care team should know about a pregnancy. Nayzilam carries specific warnings because it is kept at home. Like all benzodiazepines, it can be misused and can lead to addiction. Using it more often than prescribed can cause physical dependence, and stopping suddenly after frequent use can trigger serious withdrawal, including seizures. Store it securely and do not share it. As with other seizure medicines, it carries a small risk of new or worsening depression or suicidal thoughts; contact the prescriber right away about mood changes like these.

What to Expect

After procedural sedation, most people feel drowsy and a little unsteady, and many cannot recall the procedure or the conversation in the recovery room. Plan for an adult to take you home, and ask that person to listen to the discharge instructions, since you may not remember them. Do not drive, operate machinery or make important decisions until the drowsiness has fully worn off, and after surgery or anesthesia wait at least one full day, whichever is longer. Older adults and people with kidney, liver or heart failure may stay sedated longer. For Nayzilam, the prescriber will teach caregivers to recognize a seizure cluster worth treating, how to give the spray and what to watch for afterward. Some people with a higher risk of breathing problems receive a first trial dose under medical supervision. In the study that led to its approval, about half of people had their cluster stop within 10 minutes without a return within 6 hours, compared with about a third on a placebo spray, so it does not work every time. Needing it more often than the limits allow is a reason to review the overall seizure plan with the neurologist.

Questions to Ask Your Doctor

  1. 1.Will I receive midazolam alone or with an opioid or other medicine, and how will my breathing be monitored?
  2. 2.How long will the drowsiness and memory effects last, and when can I drive or return to work?
  3. 3.Do any of my current medicines, including antibiotics, antifungals or heart medicines, change how midazolam affects me?
  4. 4.For Nayzilam, exactly what kind of seizure episode should we treat, and when should we give a second spray or call for emergency help?
  5. 5.If we are using Nayzilam often, should we change my daily seizure treatment?

Last reviewed • Oct 2026

Educational content, not medical advice.